FDA Inspection 1018189 — Providence Health Care Institutional Review Board

Providence Health Care Institutional Review Board — FEI 3021907

The FDA completed an inspection of Providence Health Care Institutional Review Board on May 26, 2017 in Spokane, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 26, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Spokane, WA (United States)

Additional Details

IRB

Citations

IDCFRDescription
728121 CFR 56.108(a)(1)Initial and continuing reviews
729021 CFR 56.108(c)Members present for review